These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 16206398)

  • 1. PA-457, new kind of antiretroviral: ten-day clinical trial results.
    James JS
    AIDS Treat News; 2005 Aug; (414):7-8. PubMed ID: 16206398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maturation inhibitors as new antiretroviral agents.
    Richards J; McCallister S
    J HIV Ther; 2008 Dec; 13(4):79-82. PubMed ID: 19418657
    [No Abstract]   [Full Text] [Related]  

  • 3. Can the further clinical development of bevirimat be justified?
    Wainberg MA; Albert J
    AIDS; 2010 Mar; 24(5):773-4. PubMed ID: 20154583
    [No Abstract]   [Full Text] [Related]  

  • 4. FDA explores new antiretroviral trial designs: interview with David Feigal, M.D. Interview by John S. James.
    Feigal D
    AIDS Treat News; 1997 Jun; (No 273):1-5. PubMed ID: 11364399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecule of the month. PA-457.
    Drug News Perspect; 2004 May; 17(4):283. PubMed ID: 15334176
    [No Abstract]   [Full Text] [Related]  

  • 6. FDA community meeting May 16: clinical trials and viral load. Food and Drug Administration.
    AIDS Treat News; 1997 May; (No 270):3. PubMed ID: 11364324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I and II study of the safety, virologic effect, and pharmacokinetics/pharmacodynamics of single-dose 3-o-(3',3'-dimethylsuccinyl)betulinic acid (bevirimat) against human immunodeficiency virus infection.
    Smith PF; Ogundele A; Forrest A; Wilton J; Salzwedel K; Doto J; Allaway GP; Martin DE
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3574-81. PubMed ID: 17638699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maturation inhibitors: a new therapeutic class targets the virus structure.
    Salzwedel K; Martin DE; Sakalian M
    AIDS Rev; 2007; 9(3):162-72. PubMed ID: 17982941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On approval.
    Huff B
    GMHC Treat Issues; 2001 Oct; 15(10):5-8. PubMed ID: 11727570
    [No Abstract]   [Full Text] [Related]  

  • 10. The maturation inhibitor bevirimat (PA-457) can be active in patients carrying HIV type-1 non-B subtypes and recombinants.
    Yebra G; Holguín A
    Antivir Ther; 2008; 13(8):1083-5. PubMed ID: 19195334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study may point way forward for bevirimat.
    Proj Inf Perspect; 2008 Dec; (47):11. PubMed ID: 19227562
    [No Abstract]   [Full Text] [Related]  

  • 12. Opinion paper. Resistance to new anti-HIV agents: problems in the pathway of drug registration.
    Dalmau D; Klimkait T; Telenti A
    Antivir Ther; 2005; 10(7):867-72. PubMed ID: 16312184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New developments in natural products-based anti-AIDS research.
    Yu D; Morris-Natschke SL; Lee KH
    Med Res Rev; 2007 Jan; 27(1):108-32. PubMed ID: 16888749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental drug quickly suppresses HIV.
    AIDS Read; 2005 Apr; 15(4):150. PubMed ID: 15844233
    [No Abstract]   [Full Text] [Related]  

  • 15. Is it time to rethink the expanded-access programs for HIV infection?
    Amorosa V; Tebas P
    J Infect Dis; 2007 Oct; 196(7):974-7. PubMed ID: 17763316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maraviroc: new drug. Multiple antiretroviral treatment failure: too soon to reach conclusions.
    Prescrire Int; 2008 Jun; 17(95):98-101. PubMed ID: 18623908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apricitabine: a nucleoside reverse transcriptase inhibitor for HIV infection.
    Gaffney MM; Belliveau PP; Spooner LM
    Ann Pharmacother; 2009 Oct; 43(10):1676-83. PubMed ID: 19737995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FDA notifications. Tentative approval granted for combo antiretroviral drug.
    AIDS Alert; 2007 Oct; 22(10):117-8. PubMed ID: 18416009
    [No Abstract]   [Full Text] [Related]  

  • 19. T-1249 development hits a snag.
    AIDS Clin Care; 2004 Feb; 16(2):15. PubMed ID: 15032178
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug evaluation: bevirimat--HIV Gag protein and viral maturation inhibitor.
    Temesgen Z; Feinberg JE
    Curr Opin Investig Drugs; 2006 Aug; 7(8):759-65. PubMed ID: 16955688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.